Paper · 356353

Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells.

Morello D and 5 others. Transplantation, 1978. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Papers, record 356353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356353

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells.; PubMed
Journal: Transplantation; PubMed
Year: 1978; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/356353/; PubMed
DOI: https://doi.org/10.1097/00007890-197808000-00012; PubMed
The journal: https://conductscience.org/library/journal-index/0132144; PubMed
Citations, by iCite: 39; iCite
Relative citation ratio, by iCite: 0.79; iCite
Revised in PubMed: 2019-07-13; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Morello D	D
2	Gachelin G	G
3	Dubois P	P
4	Tanigaki N	N
5	Pressman D	D
6	Jacob F	F

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
H-2 Antigens	Major topic
Teratoma	Major topic
Animals
Cell Differentiation
Cytotoxicity Tests, Immunologic
Immune Sera
Immunologic Techniques
Lymphocytes
Neoplasms, Experimental
Rabbits
Radioimmunoassay
Transplantation, Heterologous

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMID	Title	Journal	Year	In Papers	Source
22,457,940	Susceptibility of allogeneic mice to teratocarcinoma 402AX.	Immunogenetics	1980	https://conductscience.org/library/papers/22457940	PubMed
7,173,948	Characterization of a new human cell line derived from a xenografted embryonal carcinoma.	In Vitro	1982	https://conductscience.org/library/papers/7173948	PubMed
6,354,707	Structure and expression of the mouse beta 2-microglobulin gene isolated from somatic and non-expressing teratocarcinoma cells.	EMBO J	1983	https://conductscience.org/library/papers/6354707	PubMed
6,161,199	Serological identification and cellular distribution of three F9 antigen components.	J Exp Med	1980	https://conductscience.org/library/papers/6161199	PubMed
4,077,147	Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.	Immunogenetics	1985	https://conductscience.org/library/papers/4077147	PubMed
3,894,422	Molecular analysis of the bare lymphocyte syndrome.	J Clin Invest	1985	https://conductscience.org/library/papers/3894422	PubMed
3,746,199	A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.	J Exp Med	1986	https://conductscience.org/library/papers/3746199	PubMed
3,554,244	A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.	Proc Natl Acad Sci U S A	1987	https://conductscience.org/library/papers/3554244	PubMed
3,322,806	Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.	EMBO J	1987	https://conductscience.org/library/papers/3322806	PubMed
3,019,667	Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice.	EMBO J	1986	https://conductscience.org/library/papers/3019667	PubMed

1 to 10 of 19

See all 19 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/356353

GET https://conductscience.org/api/papers/v1/356353/authors

API reference For AI assistants